ONGENTYS is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Neurocrine Biosciences, Inc.. The primary component is Opicapone.
Product ID | 70370-3025_62cbc1fe-da3b-436f-ba28-5dca7becb528 |
NDC | 70370-3025 |
Product Type | Human Prescription Drug |
Proprietary Name | ONGENTYS |
Generic Name | Opicapone |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2020-04-24 |
Marketing Category | NDA / NDA |
Application Number | NDA212489 |
Labeler Name | Neurocrine Biosciences, Inc. |
Substance Name | OPICAPONE |
Active Ingredient Strength | 25 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-04-24 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA212489 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2020-04-24 |
Ingredient | Strength |
---|---|
OPICAPONE | 25 mg/1 |
NDC | Brand Name | Generic Name |
---|---|---|
70370-3025 | ONGENTYS | opicapone |
70370-3050 | ONGENTYS | opicapone |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ONGENTYS 87287421 5784493 Live/Registered |
Bial-Portela & Ca., S.A. 2017-01-03 |
ONGENTYS 87287410 not registered Live/Pending |
Bial-Portela & Ca., S.A. 2017-01-03 |
ONGENTYS 79233948 not registered Live/Pending |
BIAL - PORTELA & CA., S.A. 2018-04-26 |
ONGENTYS 79103307 4228362 Dead/Cancelled |
BIAL - PORTELA & CA., S.A. 2011-08-08 |